参考文献/References:
[1] Narayanan S P,Rojas M,Suwanpradid J, et al. Arginase in retinopathy[J].Prog Retin Eye Res,2013,36(9):260-280.
[2] Duewell P,Kono H.NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals[J].Nature,2010,464(7306):1357-1361.
[3] Hou B,Zhang Y,Liang P, et al.Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype[J].Cell Death Dis,2020,1(5):377.
[4] Lim R R, Wieser M E, Ganga R R, et al. NOD-like receptors in the eye:Uncovering its role in diabetic retinopathy[J].Int J Mol Sci,2020,21(3):899.
[5] Smith L E, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse[J]. Invest Ophthalmol Vis Sci, 1994,35(1):101-111.
[6] Saddala M S,Lennikov A,Mukwaya A, et al. Discovery of novel L-type voltage-gated calcium channel blockers and application for the prevention of inflammation and angiogenesis[J].J Neuroinflammation,2020,17(1):132.
[7] Aguilar-Cazares D, Chavez-Dominguez R, Carlos-Reyes A, et al. Contribution of Angiogenesis to Inflammation and Cancer[J].Front Oncol,2019,9:1399.
[8] He C,Sun Y,Ren X,et al.Angiogenesis mediated by toll-like receptor 4 in ischemic neural tissue[J].Arterioscler Thromb Vasc Biol,2013,33(2):330-338.
[9] Friedman M, Azrad-Lebovitz T, Morzaev D, et al. Protective Effect of NLRP3 Ablation against Corneal Neovascularization following Chemical Burn in a Mouse Model[J].Curr Eye Res,2019,44(5):505-513.
[10] Chen W, Zhao M, Zhao S, et al. Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: A novel inhibitory effect of minocycline[J].Inflamm Res,2017,66(2):157-166.
[11] Chi W, Li F, Chen H, et al.Caspase-8 promotes NLRP1/NLRP3 inflammasome activation and IL-1β production in acute glaucoma[J].Proc Natl Acad Sci U S A,2014,111(30):11181-11186.
[12] Pronin A, Pham D, An W, et al. Inflammasome activation induces pyroptosis in the retina exposed to ocular hypertension injury[J]. Front Mol Neurosci,2019,12:1-16.
[13] Niu L, Zhang S, Wu J, et al.Upregulation of NLRP3 inflammasome in the tears and ocular surface of dry eye patients[J]. PLoS One,2015,10(5):e0126277.
[14] Tseng W A, Thein T, Kinnunen K, et al. NLRP3 inflamma-some activation in retinal pigment epithelial cells by lysosomal destabilization: implications for age-related macular degeneration[J].Invest Ophthalmol Vis Sci,2013,54(1):110-120.
[15] Wang Y, HanusJ, Abu-Asab M, et al. NLRP3 upregulation in retinal pigment epithelium in age-related macular degeneration[J].Int J Mol Sci,2016,17(1):73.
[16] Marneros A G.VEGF-A and the NLRP3 Inflamma-some in Age-Related Macular Degeneration[J].Adv Exp Med Biol,2016,854:79-85.
[17] Marneros A G.NLRP3 Inflammasome blockade inhibits VEGF-A-induced age-related macular degeneration[J].Cell Rep,2013,4(5):945-958.
[18] Loukovaara S, Piippo N, Kinnunen K, et al. NLRP3 inflammasome activation is associated with proliferative diabetic retinopathy[J].Acta Ophthalmol,2017,95(8):803-808.
[19] Chen Y,Wang L, Pitzer A L, et al.Contribution of redox-dependent activation of endothelial Nlrp3 inflammasomes to hyperglycemia-induced endothelial dysfunction[J].J Mol Med(Berl),2016,94(12):1335-1347.
[20] Chaurasia S S, Lim R R, Parikh B H, et al. NLRP3 inflammasome may contribute to pathologic neovascularization in the advanced stages of diabetic retinopathy[J].Sci Rep,2018,8(1):2847.